Tamoxifen May Get Blamed for Unrelated Symptoms
Perceived side effects might lead some to stop taking the breast cancer preventative, study finds (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - December 9, 2016 Category: Cancer & Oncology Source Type: news
Drug combination therapy for estrogen-receptor –positive breast cancer passes critical step for worldwide approval
Building on earlier clinical trials, UCLA researchers have confirmed that the “breakthrough” drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the harsh side effects seen in some women prescribed letrozole alone.The study, published online today in the New England Journal of Medicine, is the phase 3 study following phase 1 and phase 2 clinical trials that led toU.S. Food and Drug Administration approval of palbociclib in early 2015. Palbociclib was also approved in Europe for the first time earlier in Novem...
Source: UCLA Newsroom: Health Sciences - November 16, 2016 Category: Universities & Medical Training Source Type: news
Gwen Ifill's Death Shows We Need Better Endometrial Cancer Research
Venerated journalist and anchor Gwen Ifill died Monday at the age of 61. The cause of death was endometrial cancer, with which she was diagnosed less than a year ago.
Endometrial cancer has a reputation for being one of the most treatable and least-lethal gynecological cancers that women face. But as Ifill’s case shows, a significant minority of cases can be aggressive and fast-paced ― and they’re more likely to be concentrated among black women.
For women who have recurrent endometrial cancer, doctors have few medications that can specifically target growth.
“We don’t have as many too...
Source: Science - The Huffington Post - November 16, 2016 Category: Science Source Type: news
The 6p breast cancer pill NHS GPs deny to thousands
A study shows that three quarters of GPs are unaware of NHS guidelines telling them to offer tamoxifen to higher-risk patients and half to not know about its preventative quality. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2016 Category: Consumer Health News Source Type: news
tamoxifen (Soltamox, Nolvadex)
Title: tamoxifen (Soltamox, Nolvadex)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/4/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 4, 2016 Category: Cancer & Oncology Source Type: news
AIs May Double Risk for MI (Compared With Tamoxifen) AIs May Double Risk for MI (Compared With Tamoxifen)
The findings give medical oncologists something to consider in treating patients with breast cancer. But a pair of experts not involved with the study were cautious about the findings.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 1, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Older DCIS Patients Have Low Rates of Tamoxifen, AI Usage
The initiation of and adherence to tamoxifen or aromatase inhibitors (AIs) such as anastrozole is low among older women with estrogen receptor-positive ductal carcinoma in situ. (Source: CancerNetwork)
Source: CancerNetwork - November 1, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news
More Evidence Tamoxifen, Other Meds Help Limit Breast Cancer's Spread
6-year study finds follow-up therapy cuts survivors' risk for cancer in the other breast (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - October 7, 2016 Category: Cancer & Oncology Source Type: news
Tamoxifen linked to reduce contralateral breast cancer risk
Women should complete full course, say study authors Related items fromOnMedica Breast cancer drug ‘too costly’ for NHS Fertility treatments may impact on breast cancer risk Ten year hormonal therapy cuts breast cancer relapse Breast cancer and HRT Women denied cheap drug to stop breast cancer spread (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 6, 2016 Category: UK Health Source Type: news
More evidence tamoxifen, other meds help limit breast cancer's spread
HealthDay News Tamoxifen or a class of drugs called aromatase inhibitors do cut breast cancer patients' risk of developing cancer in their other breast, a new study finds. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 6, 2016 Category: Consumer Health News Source Type: news
More Evidence Tamoxifen, Other Meds Help Limit Breast Cancer ’ s Spread
6 - year study finds follow - up therapy cuts survivors ' risk for cancer in the other breast (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 6, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Gynecology, Nursing, Oncology, Pharmacy, News, Source Type: news
More Evidence Tamoxifen, Other Meds Help Limit Breast Cancer's Spread
6-year study finds follow-up therapy cuts survivors' risk for cancer in the other breast
Source: HealthDay
Related MedlinePlus Pages: Breast Cancer, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 6, 2016 Category: Consumer Health News Source Type: news
More Evidence Tamoxifen, Other Meds Help Limit Breast Cancer's Spread
THURSDAY, Oct. 6, 2016 -- Treatment with tamoxifen or another class of drugs called aromatase inhibitors does cut breast cancer patients ' risk of developing cancer in their other breast, a new study finds.
Some breast cancers rely on estrogen to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 6, 2016 Category: Journals (General) Source Type: news
Tamoxifen, AI therapies linked to reduced risk for contralateral breast cancer in community health
(The JAMA Network Journals) In patients with invasive breast cancer treated in a general community health care setting, tamoxifen therapy was associated with reduced risk for contralateral breast cancer in the opposite breast and that risk progressively decreased as the duration of tamoxifen therapy increased, according to a new study published online by JAMA Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 6, 2016 Category: Cancer & Oncology Source Type: news
Study may help reassure women taking tamoxifen for breast cancer
(Loyola University Health System) A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2016 Category: Global & Universal Source Type: news
